A carregar...

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia is the most common leukemia in the United States. It is a slowly progressive disease, with an 82% five-year survival rate. The treatment strategies are highly individualized with patients in the early and stable stages typically not requiring treatment. However, those wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khan, Maliha, Saif, Areeba, Sandler, Steven, Mirrakhimov, Aibek E.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003830/
https://ncbi.nlm.nih.gov/pubmed/25093123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/931858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!